TP53 mutations were detected by Sanger sequencing in 4 (5.6%) clear cell carcinomas (Supplementary Figure 1B), all of which were MDM2-low or intermediate (Supplementary Table 1). The gene discussed is TP53; the disease is clear cell adenocarcinoma.